These results indicate that lncRNA TP73-AS1 might serve as a tumor suppressor since a low expression level contributes to the progression of bladder cancer, offering a prospective therapeutic target for the treatment of this disease. This evidence concerns the gene TP73 and urinary bladder carcinoma.